Literature DB >> 25100623

Predictors of self-reported benign prostatic hyperplasia in European men: analysis of the European National Health and Wellness Survey.

Shonda A Foster1, Emily F Shortridge, Marco DiBonaventura, Lars Viktrup.   

Abstract

PURPOSE: This study aimed to identify predictors of European men who self-reported being diagnosed with benign prostatic hyperplasia (DxBPH) compared to men with moderate-to-severe lower urinary tract symptoms [American Urological Association Symptom Index (AUA-SI) score ≥8] who did not self-report a BPH diagnosis (non-DxBPH).
METHODS: Data were taken from the 2010 European National Health and Wellness Survey; a cross-sectional, self-administered, Internet-based questionnaire. This analysis included males ≥40 years with DxBPH or without DxBPH, but with AUA-SI ≥8. Chi-square tests were used for categorical variables and independent samples t tests were used for continuous variables. Logistic regressions were conducted among all men ≥40 years to predict being DxBPH.
RESULTS: About 1,638 DxBPH and 3,676 non-DxBPH men were included. The estimated prevalence of DxBPH and non-DxBPH was 8.53 and 19.13 %. Men with DxBPH were older than non-DxBPH males (mean age 66.1 and 58.3, P < 0.001). The mean AUA-SI score was 11.3 for DxBPH and 13.2 for non-DxBPH. Being older (OR = 1.077), having a university education (OR = 1.252), having private health insurance (OR = 1.186), and specific health behaviors/attitudes [regular exercise (OR = 1.191), visiting a doctor within the previous 6 months (OR = 2.398), consulting with a medical professional when not feeling well (OR = 1.097), reporting having an attentive doctor (OR = 1.112)], and higher voiding symptoms (OR = 1.032) were significant predictors of DxBPH.
CONCLUSIONS: Older men with higher education and access to care and more engagement in their healthcare were more likely to self-report being diagnosed.

Entities:  

Mesh:

Year:  2014        PMID: 25100623     DOI: 10.1007/s00345-014-1366-6

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  19 in total

Review 1.  The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip Van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Urology       Date:  2003-01       Impact factor: 2.649

2.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.

Authors:  M J Barry; F J Fowler; M P O'Leary; R C Bruskewitz; H L Holtgrewe; W K Mebust; A T Cockett
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

Review 3.  Coexisting lower urinary tract symptoms and erectile dysfunction: a systematic review of epidemiological data.

Authors:  A D Seftel; J de la Rosette; J Birt; V Porter; V Zarotsky; L Viktrup
Journal:  Int J Clin Pract       Date:  2012-10-22       Impact factor: 2.503

4.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

5.  The prevalence of bother, acceptance, and need for help in men with erectile dysfunction.

Authors:  B J de Boer; M L Bots; A A B Lycklama A Nijeholt; J P C Moors; Th J M Verheij
Journal:  J Sex Med       Date:  2005-05       Impact factor: 3.802

6.  Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder.

Authors:  Debra E Irwin; Ian Milsom; Zoe Kopp; Paul Abrams; Walter Artibani; Sender Herschorn
Journal:  Eur Urol       Date:  2009-03-03       Impact factor: 20.096

7.  The prevalence of lower urinary tract symptoms in men and women in four centres. The UrEpik study.

Authors:  P Boyle; C Robertson; C Mazzetta; M Keech; F D R Hobbs; R Fourcade; L Kiemeney; C Lee
Journal:  BJU Int       Date:  2003-09       Impact factor: 5.588

8.  An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.

Authors:  Man-Kay Li; Lester Garcia; Nelson Patron; Lei Chang Moh; Murali Sundram; Somboon Leungwattanakij; Choosak Pripatnanont; Christopher Cheng; Man Chi-Wai; Ngai Loi-Cheong
Journal:  BJU Int       Date:  2007-11-13       Impact factor: 5.588

9.  Identifying patients with benign prostatic hyperplasia through a diagnosis of, or treatment for, erectile dysfunction.

Authors:  Kevin McVary; Kathleen A Foley; Stacey R Long; Stephen Sander; Tammy G Curtice; Hemal Shah
Journal:  Curr Med Res Opin       Date:  2008-01-30       Impact factor: 2.580

10.  Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).

Authors:  Raymond Rosen; Jens Altwein; Peter Boyle; Roger S Kirby; B Lukacs; Eric Meuleman; Michael P O'Leary; Paolo Puppo; Chris Robertson; Francois Giuliano
Journal:  Eur Urol       Date:  2003-12       Impact factor: 20.096

View more
  2 in total

1.  Heritability and genome-wide association study of benign prostatic hyperplasia (BPH) in the eMERGE network.

Authors:  Jacklyn N Hellwege; Sarah Stallings; Eric S Torstenson; Robert Carroll; Kenneth M Borthwick; Murray H Brilliant; David Crosslin; Adam Gordon; George Hripcsak; Gail P Jarvik; James G Linneman; Parimala Devi; Peggy L Peissig; Patrick A M Sleiman; Hakon Hakonarson; Marylyn D Ritchie; Shefali Setia Verma; Ning Shang; Josh C Denny; Dan M Roden; Digna R Velez Edwards; Todd L Edwards
Journal:  Sci Rep       Date:  2019-04-15       Impact factor: 4.379

2.  Sociodemographic Factors Related to Lower Urinary Tract Symptoms in Men: A Korean Community Health Survey.

Authors:  Jung Ki Jo; Kyu Shik Kim; Ji Won Nam; Bo Yul Choi; Hong Sang Moon
Journal:  Int Neurourol J       Date:  2017-06-21       Impact factor: 2.835

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.